Ta-NPs (2% Tumor Volume)
HX 2026-937
Phase 1 mab active
Quick answer
Ta-NPs (2% Tumor Volume) for Locally Recurrent Retroperitoneal Soft Tissue Sarcoma is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active